Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
FTC chair Lina Khan to Senate: Big Pharma M&A is still a priority target
3 years ago
Deals
Boehringer sings a new tune with spokesperson Bernie Williams in newest lung disease campaign
3 years ago
Marketing
Two CRLs later, FDA endorses drug to prevent hearing loss associated with chemo
3 years ago
FDA+
Despite progress, women are 'severely underrepresented' in biotech — report
3 years ago
J&J talc plaintiffs petition federal court to block the pharma's 'Texas two-step' maneuver
3 years ago
Law
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
3 years ago
Law
Rising overdose deaths: Ohio State experts to review FDA's opioids plan and provide 'actionable recommendations'
3 years ago
FDA+
Bavarian Nordic inks another major vaccine contract with Canada
3 years ago
Manufacturing
EMA takes a stand against interchangeability, says all approved biosimilars are interchangeable
3 years ago
FDA+
Lab coats and microscopes in marketing: Does science still sell in pharma advertising?
3 years ago
Marketing
MarketingRx roundup: Sanofi debuts branded 'Just the Flu' ad; Pfizer, BioNTech promote boosters with college football
3 years ago
Marketing
Long after first nod for inhaled Tyvaso, United Therapeutics scraps PhIII in PH with COPD
3 years ago
R&D
Heron secures FDA approval after R&D head count chop
3 years ago
FDA+
Seagen secures a speedy FDA review on Tukysa as Merck buyout talks reportedly stall
3 years ago
FDA+
Astellas taps TikTok influencers to talk menopause symptoms in a first pharma move
3 years ago
Marketing
Vanda inks $11.5M deal to settle off-label drug promotion accusations
3 years ago
Law
First the US, now the EU: Pfizer’s 20-valent pneumococcal jab for infants headed to regulators
3 years ago
R&D
Bluebird lands another rare disease gene therapy OK — but there are a few caveats to note
3 years ago
Cell/Gene Tx
FDA+
Still carrying the budget axe, Kåre Schultz is wrapping up his stint at Teva, promising to start paying opioid settlement
3 years ago
People
Moderna CEO looks to Japan for building new vaccine manufacturing site
3 years ago
Coronavirus
Manufacturing
AmerisourceBergen throws down nearly $1.3B cash for German life sciences company
3 years ago
Deals
HHS promotes 'updated' Covid vaccines in next phase of 'We Can Do This' ad campaign
3 years ago
Marketing
Ahead of FDA, EMA gives thumbs-up to AstraZeneca, Sanofi's RSV antibody for infants and newborns
3 years ago
New report digs into top blockbusters and their reliance on patents to block competition
3 years ago
Law
First page
Previous page
172
173
174
175
176
177
178
Next page
Last page